HIV trials in Peru

In Peru 10 Also abroad 789

10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Not yet taking people in Peru
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
Where
Lima
Age
18 years to 70 years
People
40 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06987318
Phase 2/3Taking people
Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Where
Lima
People
2,530 worldwide
Run by
Johns Hopkins University
See details and how to joinNCT06568484
Phase 2Taking people
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Where
Lima
Age
18 years to 70 years
People
48 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05719441
Phase 1Taking people
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Where
Bellavista, Lima Cercado
Age
18 years to 60 years
People
40 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06665646
Phase 1Taking people
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
Where
Bellavista, Lima
Age
18 years to 60 years
People
42 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07569029
Phase 1Not yet taking people in Peru
A Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy Adults
Where
Iquitos, Lima
Age
18 years to 55 years
People
116
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07818824
No phaseTaking people
Peru Decentralized HIV Care
Where
Bellavista
Age
18 years and over
People
1,450 worldwide
Run by
Yale University
See details and how to joinNCT05910268
Phase 1Taking people
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
Where
Bellavista, Lima Cercado
Age
18 years to 55 years
People
83 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07390955
No phaseNot yet taking people in Peru
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
Where
Lima
Age
18 years and over
People
139
Run by
Yale University
See details and how to joinNCT07053514
Phase 3Not yet taking people in Peru
Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
Where
Lima
Age
18 years to 29 years
People
400 worldwide
Run by
HIV Prevention Trials Network
See details and how to joinNCT07658976